NEW YORK STATE COMMON RETIREMENT FUND - IMPEL NEUROPHARMA INC ownership

Back to all holdings Add to watchlist

IMPEL NEUROPHARMA INC's ticker is IMPL and the CUSIP is 45258K109. A total of 37 filers reported holding IMPEL NEUROPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Links
Filings
External links
Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of IMPEL NEUROPHARMA INC
ValueSharesWeighting
Q2 2022$0
-100.0%
45
-99.3%
0.00%–
Q1 2022$44,000
-25.4%
6,847
-0.3%
0.00%–
Q4 2021$59,000
-29.8%
6,8670.0%0.00%–
Q3 2021$84,000
-30.6%
6,867
-49.9%
0.00%–
Q2 2021$121,000–13,700–0.00%–
 Download
Other shareholders
IMPEL NEUROPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
NVP Associates, LLC 3,077,198$11,539,49311.26%
Vivo Capital, LLC 2,884,789$43,2724.98%
venBio Partners LLC 2,759,791$10,349,2163.21%
5AM Venture Management, LLC 2,884,791$10,817,9662.91%
LASRY MARC 408,329$1,531,2342.38%
DCF Advisers, LLC 325,825$1,221,8440.83%
Kohlberg Kravis Roberts & Co. L.P. 4,135,971$15,509,8910.52%
EPIQ PARTNERS, LLC 18,646$69,9230.05%
J. Goldman & Co LP 200,219$750,8210.04%
MCDONALD PARTNERS LLC 11,700$43,8750.02%
View complete list of IMPEL NEUROPHARMA INC shareholders